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Abstract 
Background:  Fatigue has been under-investigated in stable kidney transplant recipients 
(KTRs).  The objectives of this study were to investigate the nature, severity, prevalence and 
clinical awareness of fatigue in medically stable KTRs, examine the impact of fatigue on 
quality of life (QoL), and explore the underlying causes of post-transplant fatigue. 
Methods:  This single-centre cross-sectional study enrolled 106 stable KTRs.  Multi-
Dimensional Fatigue Inventory (MFI-20) was used to measure 5 fatigue dimensions:  General 
Fatigue (GF), Physical Fatigue (PF), Reduced Activity (RA), Reduced Motivation (RM), 
Mental Fatigue (MF).  Clinical awareness of fatigue was determined by reviewing medical 
records.  QoL was assessed by Medical Outcomes Study Short Form (SF-36) Questionnaire.  
Demographic, clinical, psychosocial and behavioural parameters were evaluated as fatigue 
predictors.  
Results:  Fatigue was found in 59% of KTRs.  Only 13% had this symptom documented in 
medical records.  Fatigue in KTRs was in the same range as chronically unwell patients, with 
PF, RA and RM approached levels observed in chronic fatigue syndrome.  All fatigue 
dimensions significantly and inversely correlated with QoL (p<0.001 for all associations).  
Demographic predictors were male, older age and non-Caucasian ethnicity (p≤0.05 for all 
associations).  Clinical predictors included elevated hsCRP (inflammation), decreased eGFR 
(graft dysfunction), and reduced lean tissue index (p≤0.05 for all associations).  Psychosocial 
and behavioural predictors were inferior sleep quality, anxiety and depression (p<0.01 for all 
associations). 
Conclusions:  Fatigue is common and pervasive in clinically stable KTRs.  It is strongly 
associated with reduced QoL.  This study identified modifiable fatigue predictors, and sets 
the scene for future interventional studies.  
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Fatigue is an important patient-reported outcome in many medical conditions (1, 2) and 
involves physical (e.g. feeling exhausted and tired), cognitive (e.g. impaired concentration), 
emotional (e.g. lack of motivation) and functional components (3).  It is often medically 
unexplained (4) and persistent (2), and interferes with an individual’s ability to function in 
important roles (e.g. work, family, social life, self-care) (5).  As a corollary, fatigue can have 
a major negative impact upon quality of life (QoL) (6). 
 
In chronic dialysis patients, fatigue is frequently reported as a pervasive and distressing 
symptom (7-9).  For many of these patients, kidney transplantation (KT) is the preferred 
modality of renal replacement therapy (10).  KT increases long term survival (10), improves 
QoL (11), demonstrates cost benefits (12), and results in enhanced sense of well-being.  
Consequently, it might be assumed that fatigue no longer feature as a major problem 
following KT, but in fact there has been very little research to either confirm or refute this 
assumption.  Only one study has specifically examined fatigue following transplantation (13), 
noting the symptom was reported in 59% of kidney transplant recipients (KTRs) and that it 
negatively impacted on virtually every aspect of the QoL (13).  Poor sleep quality, mood 
disturbance and raised body mass index were identified as significant predictors for post-
transplant fatigue (13).  However, other potentially modifiable contributors to fatigue such as 
body composition, inflammation, renal function, and other biochemical markers were not 
examined and warrant further investigation.    
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Greater insight into fatigue severity, its impact on QoL, and its possible underlying causes are 
all pre-requisites for developing interventions to combat this symptom.  In addition, it is also 
important to know the extent to which clinicians are aware of the problem.  Therefore, the 
objectives of this study were to determine the nature, severity, prevalence and clinical 
awareness of post-transplant fatigue in a clinically-stable prevalent kidney transplant cohort.  
Additionally, this study aimed to examine the impact of this symptom upon QoL, and to 






The characteristics of the studied population are shown in Table 1. 
 
Relationship between different domains of fatigue 
 
The correlations between different domains of fatigue are shown in Table 2. 
 
Nature, severity and prevalence of fatigue 
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The nature and severity of fatigue are shown in Table 3, alongside normative data obtained 
from Lin’s study (14).  Comparison of the Multi-Dimensional Fatigue Inventory (MFI-20) 
subscales indicated that significant differences were found between the following 
dimensions:  General Fatigue [GF] and Reduced Activity [RA] (p=0.002); GF and Reduced 
Motivation [RM] (p<0.001); GF and Mental Fatigue [MF] (p<0.001); Physical Fatigue [PF] 
and RA (p=0.002); PF and RM (p<0.001); PF and MF (p<0.001); RA and RM (p<0.001); RA 
and MF (p<0.001).  The differences between the following dimensions were not statistically 
significant:  GF and PF (p=0.881); RM and MF (p=0.801).  In summary, physical aspects of 
fatigue (GF and PF) in KTRs were scored significantly higher than behavioural, emotional 
and cognitive aspects of fatigue (RA, RM and MF).  Overall, the mean MFI-20 scores in 
KTRs exceeded the mean scores found in the general population and were comparable to the 
mean scores reported by chronically unwell patients.  In fact, the mean scores for PF, RA and 
RM approached the mean values reported by Chronic Fatigue Syndrome (CFS) patients. 
 
Based on the dichotomous classification of fatigue (≥ upper 95th percentile for the general 
population, see Materials and Methods), a total of 63 patients (59%) reported fatigue on at 
least one MFI-20 subscale.  Of these 63 patients, 24% experienced GF, 38% displayed PF, 
35% demonstrated RA, 29% indicated RM, and 25% revealed MF.  Importantly, only 8 
patients (13%) had complaints of fatigue documented in medical records.   
 
Fatigue and quality of life 
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As shown in Table 4, all dimensions of fatigue (GF, PF, RA, RM and MF) were significantly 
and inversely correlated with all aspects of QoL including SF-36 physical health, SF-36 
mental health and SF-36 total score.  To exclude the confounding effect of the SF-36 “energy 
and vitality” subscale, which is a general measure of fatigue within the SF-36 (15), results 
were reanalysed after removal of this subscale, results were comparable after this exclusion 
(shown in parentheses in Table 4). 
 
Factors predicting dimensions of fatigue 
 
Linear regression analyses, to identify predictors of each fatigue dimension, were performed 
in 3 stages.  First, univariate analyses tested the predictive value of each parameter 
individually.  Second, multivariate analyses tested the independent prediction of all 
parameters.  Third, the analysis was adjusted for anxiety, depression, and sleep quality, 
thereby focusing on clinical, anthropometric and laboratory parameters. 
 
General Fatigue 
The univariate analyses are shown in SDC, Table 5a.  In multivariate analysis, only 
depression (β=2.8; 95% CI=1.9, 3.7; p<0.001) and inferior sleep quality (β=1.1; 95% CI=0.2, 
1.9; p=0.01) were independently associated with GF (SDC, Figure 1 and SDC, Figure 2).  
Repeating the multivariate analysis excluding Hospital Anxiety and Depression Scale 
(HADS) and Pittsburgh Sleep Quality Index (PSQI) revealed that increasing time post-
transplantation (β=0.6; 95% CI=0.0, 1.1; p=0.04), inflammation (β=1.8; 95% CI=0.3, 3.3; 
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p=0.02), and renal dysfunction (β=-0.4; 95% CI=-0.8, 0.0; p=0.04) were independently 
associated with increasing fatigue. 
 
Physical Fatigue 
The univariate analyses are shown in SDC, Table 5b.  In the multivariate model, depression 
(β=3.2; 95% CI=2.3, 4.1; p<0.001), renal dysfunction (β=-0.7; 95% CI=-1.4, -0.5; p<0.001; 
SDC, Figure 3), inflammation (β=1.4; 95% CI=0.0, 2.7; p=0.05), reduced LTI (β=-0.5; 95% 
CI=-0.8, -0.3; p<0.001; SDC, Figure 4) and male (β=2.4; 95% CI=0.9, 4.0; p=0.003) were 
independently associated with PF.  Repeating the multivariate analysis excluding HADS and 
PSQI showed that renal dysfunction (β=-0.8; 95% CI=-1.2, -0.4; p<0.001), inflammation 
(β=2.6; 95% CI=1.0, 4.1; p=0.002), increasing time post-transplantation (β=0.7; 95% CI=0.2, 
1.3; p=0.01), reduced LTI (β=-0.6; 95% CI=-0.9, -0.3; p<0.001), and male (β=3.1; 95% 
CI=1.2, 5.0; p=0.001) were independently associated with PF.   
 
Reduced Activity 
The univariate analyses are shown in SDC, Table 5c.  In the multivariate model, depression 
(β=3.4; 95% CI=1.9, 3.7; p<0.001), inflammation (β=2.7; 95% CI=1.2, 4.1; p<0.001; SDC, 
Figure 5), and increasing age (β=0.7; 95% CI=0.2, 1.1; p=0.003) were independent 
predictors for RA.  Following exclusion of HADS and PSQI, inflammation (β=3.8; 95% 
CI=2.2, 5.4; p<0.001), increasing comorbidity (β=3.4; 95% CI=1.0, 5.7; p=0.006), increasing 
time post-transplantation (β=0.6; 95% CI=0.0, 1.2; p=0.04), and increasing age (β=0.6; 95% 
CI=0.2, 1.1; p=0.04) were independently associated with RA.   
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Reduced Motivation 
The univariate models are shown in SDC, Table 5d.  In the multivariate analysis, depression 
(Odds Ratio = 1.40; CI=1.30, 1.52; p<0.001), renal dysfunction (Odds Ratio = 0.96; CI=0.93, 
1.00; p=0.03), and reduced LTI (Odds Ratio = 0.98; CI=0.96, 1.00; p=0.05) were associated 
with RM independently.  Following exclusion of HADS and PSQI, increasing time post-
transplantation (Odds Ratio = 1.07; CI=1.01, 1.13; p=0.02), renal dysfunction (Odds Ratio = 
0.95; CI=0.92, 0.99; p=0.02), and inflammation (Odds Ratio = 1.22; CI=1.05, 1.43; p=0.01) 
were independent predictors for RM. 
 
Mental Fatigue 
Finally, the univariate analyses predicting MF are shown in SDC, Table 5e.  In the 
multivariate model, only anxiety was independently associated with fatigue (Odds Ratio = 
1.36; CI=1.24, 1.49; p<0.001; SDC, Figure 6).  A borderline effect of ethnicity was found 
(Odds Ratio = 1.42; CI=1.01, 1.99; p=0.05).  When the multivariate analysis was repeated 




This study aimed to investigate the nature, severity, prevalence and clinical awareness of 
post-transplant fatigue, determine the association between fatigue and QoL, and identify main 
predictors of post-transplant fatigue.  The results revealed that in clinically stable KTRs 
without evidence of intercurrent disease, fatigue is common, severe, and clinically under-
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appreciated.  It has a close association with inferior QoL.  These results confirm and 
significantly extend the findings of the single previous study on post-transplant fatigue (13), 
and advances understanding of the possible determinants of fatigue by showing associations 
with anthropometric and clinical variables not previously evaluated.  Depression, anxiety, 
inferior sleep quality, inflammation, reduced muscle mass, and renal dysfunction were 
identified as risk factors, forming potential targets for future interventional studies. 
 
The significant correlations between different domains of fatigue suggest that treatment of 
behavioural, emotional and cognitive aspects of fatigue may improve physical aspects of 
fatigue, or vice versa.  However, a recent study provides experimental evidence that mental 
fatigue limits exercise tolerance in humans via higher perception of effort rather than 
cardiorespiratory and musculoenergetic mechanisms (16), implying that the overall focus of 
fatigue management should be on the behavioural, emotional and cognitive aspects.   
 
Compared to normative data from healthy population (14, 17), KTRs suffer from higher 
levels of fatigue on all dimensions.  In comparison to normative data from Lin (14), fatigue 
levels in KTRs were similar to “chronically unwell” patients, defined as having chronic (≥ 6 
months) unwellness with or without fatigue, but not meeting criteria for CFS (14).  Indeed, 
severity in certain domains, such as PF, RA and RM, approached that of CFS (14), further 
highlighting the burden of fatigue in KTRs.  Of note, the level of MF was higher in KTRs 
compared to cancer patients with mild anaemia undergoing chemotherapy (17), and chronic 
heart failure patients with and without anaemia (18).  Also, KTRs suffer from higher levels of 
PF, RA and RM compared to cancer patients without anaemia (17).  Physical aspects of 
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fatigue outweighed behavioural, emotional and cognitive aspects, resembling findings in liver 
transplant recipients (19).   
 
Using a dichotomous fatigue definition, 24-38% of participants reported fatigue in at least 
one of the five dimensions, and 59% in any dimension.  This prevalence is comparable to that 
found by Rodrigue (13) using the one-dimensional “Fatigue Symptom Inventory”.  Despite 
the high prevalence, only 13% of patients had fatigue documented in medical records prior to 
participation in this study, suggesting that this symptom is either under-reported or under-
acknowledged.  Furthermore, the close correlation between all fatigue domains and QoL 
resonates with the clinical and social relevance of this symptom.   
 
The assessment of multiple domains of fatigue, and the measurement from the clinically 
validated HADS extends the findings of Rodrigue (13) where fatigue severity significantly 
correlated with a composite mood score incorporating depression, vigour, anger, confusion, 
anxiety and fatigue itself.  The current study highlights the specific, independent importance 
of depression as a risk factor for all dimensions of fatigue except for MF.  This exception is 
surprising as previous study on multiple sclerosis (MS) related fatigue found that depression 
was related to MF (20, 21).  However, depression and MF can occur independently or 
simultaneously (22), this phenomenon has been demonstrated in stroke patients (22) .  Many 
symptoms for depression and MF overlap, but the core symptoms are different.   The lack of 
association in this study may be explained by the distinction between the core symptoms.  
Depression is an illness or mood disorder with a variety of symptoms, the most defining 
being an inexplicable, enduring feeling of sadness, and loss of positive effect (23).  The 
collective symptoms may not manifest as MF, which is a psychobiological state caused by 
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prolonged periods of demanding cognitive activity such as concentration, attention and 
increased mental load (16).  In MF, mental effort can only be sustained for a short time-
frame, and recovery period is disproportionally long (22).  Accompanying symptoms include 
irritability, sensitivity to stress, concentration difficulties, and emotional instability (22).  
Anxiety was a significant predictor for MF, similar to other chronic conditions such as MS 
(21).  KTRs are subjected to several mental challenges, including fears about transplant 
rejection and the necessity to adhere to a complex regimen of immunosuppression therapy 
that may generate distressing side effects (24).  To an extent, the unpredictable clinical course 
post-transplantation is reminiscent of the relapsing and remitting nature of MS.  While 
acknowledging the limitations of cross-sectional data to make causal inferences, the present 
results are in line with evidence showing that psychological interventions addressing disease-
related anxiety and depression per se may yield added benefit in modifying fatigue. 
 
While inferior sleep quality may intuitively be expected to have a pervasive and broad effect 
on multiple aspects of fatigue (13), a significant association was only observed for the GF 
dimension.  This finding suggests that mere sleep difficulties do not explain a large spectrum 
of the fatigue complaints in KTRs, and interventions aiming to improve sleep quality may 
have limited effect on fatigue. 
 
An important caveat with the interpretation of the associations between self-reported data, 
such as depression, sleep difficulties and symptoms of fatigue is that common-method 
variance (CMV) may partly drive the observed associations, and may account for 25% of 
shared variance (25).  In CMV, patients high in negative affect (i.e. negative mood) perceive, 
remember and report more physical and psychological symptoms, and report those symptoms 
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to be more severe than patients with a less negative mood (26).  Additionally, individual 
items on questionnaires measuring fatigue, depression or sleep problems tend to show 
conceptual overlap, which further enhances co-variation.  While these would not render self-
reports unimportant, and neither would refute that sleep and depression may have strong 
bidirectional links with fatigue, potential interpretational difficulties may result.  Therefore, 
this study’s detailed anthropometric and biochemical data represents an important extension 
of the previous study in the field (13).  When multivariate regression analysis excluded 
adjustment for mood and sleep, reduced LTI, renal impairment and inflammation were 
identified as potentially reversible predictors. 
 
The association between inflammation and fatigue is particularly notable as the studied 
cohort consisted of clinically stable KTRs, without overt evidence of ongoing acute or 
chronic inflammatory conditions.  Evidence from studies of healthy volunteers, elderly 
populations and other disease groups have shown that inflammatory cytokines possess potent 
neurological effects and are mediators of fatigue (13, 27-30).  Modifying inflammation may 
therefore represent an attractive target in future studies. 
 
The independent association between physical fatigue and reduced LTI is intuitively 
plausible, but not previously reported in KTRs.  It replicates results from cancer-related 
fatigue (31), and fatigue associated with end-stage renal disease on haemodialysis (32, 33).  
Reduced muscle mass coupled with increased fat mass (“sarcopenic obesity”) is a common 
characteristic of body composition following KT (34).  Despite significant univariate 
associations between FTI and different dimensions of fatigue (GF, PF, RA and RM), this 
relationship did not hold when adjusted for inflammation, suggesting inflammation as the 
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driver for fatigue, rather than adiposity per se.  This study advances understanding from 
Rodrigue (13) where raised BMI (a proxy for fat mass) was identified as a predictor of 
fatigue, but detailed anthropometric and inflammatory evaluation was not undertaken.   
However, it is possible that the systemic low-grade inflammation present in obesity triggers 
adipocyte release of pro-inflammatory cytokines (35), this in turn accelerates muscle 
catabolism (36), leading to muscle wasting (36).  The current study suggests that lifestyle 
interventions with a strong focus on increased physical activity and dietary modification 
aiming to reverse this phenotype should be valuable for patients displaying symptoms of 
fatigue.  Apart from promoting favourable changes in body composition, lifestyle 
modification is particularly important in light of the inverse associations between all domains 
of fatigue and SF-36 physical health subscale, which is a representation of self-perceived 
physical functioning.  Recent studies reported that self-perceived physical functioning is 
significantly and positively correlated with physical activity level (37, 38).  Although 
physical activity level was not measured in the current study, this finding suggests that 
striving to be physically active enhances functional capacity and improves self-perception of 
physical functioning, leading to improved fatigue and quality of life. 
 
Although fatigue is a common and important symptom for patients on dialysis (7, 8), the 
present results show, for the first time, a relationship between allograft dysfunction and 
physical fatigue in KTRs.  Clinical strategies exist to improve allograft function (39) and 
fatigue may represent an important patient-reported outcome in future interventional studies.   
 
Other non-modifiable, but important, risk factors for varying domains of fatigue included 
male, older age, ethnicity, comorbidity, and increasing time post-transplantation.  
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The lack of association between haemoglobin level and fatigue is unsurprising as the results 
from the TREAT study (Trial to Reduce cardiovascular Events with Aranesp Therapy) (40) 
only showed a small improvement in fatigue with haemoglobin normalisation, using 
recombinant erythropoietin in non-transplant, diabetic, chronic kidney disease. 
 
The use of immunosuppressive medication was not associated with fatigue in KTRs.  Of 
relevance, no link between immunosuppression and fatigue was seen in previous studies of 
liver transplant recipients (19) and KTRs (13).    
 
This study has limitations that should be acknowledged.  It is a single-centre study with a 
small sample size.   The progression and regression of fatigue over time could not be 
evaluated due to the study design of cross-sectional nature.  The results may not be 
representative of “sicker” patients within the transplanted population.  It is recognised that 
hyperparathyroidism occurs in a substantial proportion of KTRs (17%) (41), with fatigue as a 
possible manifestation.    Unfortunately, serum parathyroid hormone concentrations were not 
routinely measured in this study.   
 
Whilst kidney transplantation is associated with a variety of benefits compared with dialysis, 
this study shows that fatigue remains a common and relevant problem in otherwise stable 
KTRs.  As the medical complexity of KTRs increases, it is important not to lose sight of 
important patient-reported outcomes such as fatigue.  This study demonstrates potential 
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targets for intervention, and future research should focus on evaluating the effectiveness and 
impact of such interventions upon fatigue and QoL. 
 
Materials and Methods 
 
Participants and study design 
 
Stable KTRs beyond 1 year post-transplantation, with stable graft function (<10% increase in 
serum creatinine over preceding 6 months) were recruited to this cross-sectional study from 
the renal transplant outpatient clinic at Queen Elizabeth Hospital Birmingham UK, between 
April 2010 and April 2012.  Exclusion criteria included episodes of acute rejection within the 
last 6 months, evidence of sepsis in the last 6 weeks, known active malignancy or chronic 
infection, preceding diagnosis of psychiatric disorder or chronic fatigue syndrome, and 
history of thyroid disease or adrenal insufficiency.   
 
Of 114 eligible patients approached, n=6 refused to participate and n=2 did not attend the 
research visit.  Reasons for declining entry were work commitment (n=4) and participation in 
other studies (n=2).  The study was approved by the local research ethics committee, and was 
conducted in accordance with the principles of the Declaration of Helsinki. 
 
Patients attended the research visit following a 10-hour overnight fast.  The order of tests was 
standardised.  A fasting blood sampling was taken, followed by a light breakfast before bio-
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impedance body composition assessment, and self-completion of questionnaires under 




Severity and nature of fatigue were determined using the MFI-20, which is a 20-item self-
report questionnaire that measures fatigue in 5 primary dimensions: General Fatigue (GF); 
Physical Fatigue (PF); Reduced Activity (RA); Reduced Motivation (RM); Mental Fatigue 
(MF).  The physical aspects of fatigue are captured by GF and PF; and the behavioural, 
emotional and cognitive aspects of fatigue are represented by RA, RM, and MF (42) (see 
SDC, Materials and Methods for scoring and description of MFI-20). 
 
A consensus definition for clinically meaningful fatigue is lacking.  In this study, KTRs were 
considered fatigued if scores for any dimension was ≥ upper 95th percentile for the general 
population as reported by Lin (14) (GF ≥ 15; PF ≥ 14; RA ≥ 12; RM ≥ 12; MF ≥ 13).  The 
present data were also compared with two other clinical groups, similarly derived from Lin 
(14), namely patients with CFS and patients with other chronic (> 6 months) diseases. 
 
Reporting of fatigue by clinicians was assessed by retrieving medical records for the 4 clinic 
visits prior to participation in this study (see SDC, Materials and Methods for explanation 
of medical record retrieval).   
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Quality of life assessment 
 
QoL was assessed using the Medical Outcomes Study Short Form 36 (SF-36) questionnaire, 
which generates the total score for QoL, as well as physical health and mental health sub-
scores (see SDC, Materials and Methods for scoring and description of SF-36).  
 
Factors associated with fatigue  
 
Demographics and clinical parameters 
Age, gender, marital status, ethnicity, and time post-transplantation were collected from 
patients’ medical records.  Smoking status (never smoked, current smoker, ex-smoker) and 
alcohol intake (units per week) were collected by questionnaire.  Co-morbidity was assessed 
by Index of Co-Existing Disease (ICED), using the algorithm described by the Hemodialysis 
(HEMO) Study (43), with data extracted from patients’ medical records.  Presence of 
diabetes, either pre-transplantation (pre-DM) or new onset diabetes after transplantation 
(NODAT), prior acute rejection episodes, and immunosuppressive medication usage were 
retrieved from patients’ medical records. 
 
Laboratory parameters 
Fasting blood sample was taken for analysis of high sensitive C-reactive protein (hsCRP), 
haemoglobin (Hb) and estimated glomerular filtration rate (eGFR) derived using the 4-
variable modification of diet in renal disease equation (44). 
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Body composition 
Body composition was assessed by multi-frequency bio-impedance measurement, using the 
body composition monitor to provide values for Lean Tissue Index (LTI) and Fat Tissue 
Index (FTI) (see SDC, Materials and Methods for explanation of bio-impedance 
measurement).   
 
Self-reported outcome measures 
Anxiety and Depression were assessed using the Hospital Anxiety and Depression Scale 
(HADS) (45).  Sleep quality was assessed by the Pittsburgh Sleep Quality Index (PSQI) (46).  




Statistical analysis was performed using STATA.  Results are presented as mean ± standard 
deviation or median (interquartile range).  Independent sample t-tests were used to compare 
continuous variables, and Pearson correlation coefficients to assess relationship. 
 
Linear regression analysis was used to determine predictor variables associated with different 
domains of fatigue.  The analyses were performed in two stages.  Initially, the effect of each 
variable was examined in a series of univariate analyses.  Subsequently, the joint effect of 
variables was examined in a multivariate analysis, using a backwards selection procedure to 
derive the final model.  A type 1 error rate ≤5% (p≤0.05) was considered significant.  Results 
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for GF, PF and RA revealed normal distributions and were analysed on the original scale of 
measurement.  Results for RM and MF demonstrated positively skewed distributions and 
underwent logarithmic transformation prior to analysis.  In the multivariate regression 
analyses, only the explanatory variables with univariate p-values of <0.20 were included.  
The figures reported in SDC, Tables 5a, 5b, 5c, 5d and 5e, were regression coefficients or 
odds ratios, and their corresponding confidence intervals.    The regression coefficients and 
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Table 1:  Population Characteristics 
 Characteristics 
 
Sample size n = 106  
†Mean age 51 ± 14 years 
Gender  56% Male; 44% Female 
Marital status Single 21%; Married 71%; Divorced/Widowed 8%  





89% (55% Tacrolimus, 34% Cyclosporin) 
87% (58% Mycophenolate Mofetil, 29% Azathioprine) 
74%  
Dosage of immunosuppressive medications 
‡Median dose of Tacrolimus 
‡Median dose of Cyclosporin 
†Mean dose of Mycophenolate Mofetil 
†Mean dose of Azathioprine  
†Mean dose of Prednisolone 
 
4.0 (2.5-6.0) mg/day 
150 (150-200) mg/day 
987 ± 392 mg/day 
77 ± 36 mg/day 











‡Median time post transplantation 6.5 (3.0-14.0) years 
‡Median alcohol intake per week 0.0 (0.0-3.0) units 
Smoking status 
Never smoked  






†**Mean ICED score (co-morbidity) 
Score = 1 
Score = 2 
Score = 3 




†Mean Hb 12.6 ± 1.6 g/dl 
‡Median hsCRP 2.5 (1.0-4.9) mg/l 
†Mean eGFR 43.9 ± 18.5 ml/min 
Body composition 
†Mean lean tissue index (LTI) 
†Mean fat tissue index (FTI) 
 
13.9 ± 3.0 kg/m2 
14.2 ± 6.2 kg/m2 
HADS 
‡Median anxiety score 





†Mean global score 
 
7.2 ± 4.1 
†Normally distributed data, results expressed as mean ± SD.   ‡Non-normally distributed data, results expressed as median (Interquartile 
Range).  *For the purpose of the statistical analysis, the ethnicity of 2% of patients classified as “Other” was grouped as “Caucasian”.  **For 
the purpose of the statistical analysis, the Index of Co-Existent Disease (ICED) scores were arranged into 2 categories (≤2 versus >2, 87% 
and 13% of patients respectively).   
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Table 2:  Correlation between different domains of fatigue 
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Table 3:  Nature and Severity of Fatigue 
 














General Fatigue  
(GF) 
 
11.78 ± 4.05 8.42 ± 3.59 12.84 ± 3.84 16.38 ± 2.73 
Physical Fatigue  
(PF) 
 
11.73 ± 4.74 7.77 ± 3.36 10.39 ± 3.76 13.63 ± 3.79 
Reduced Activity  
(RA) 
 




9.36 ± 3.61 6.82 ± 2.91 9.29 ± 3.35 11.95 ± 3.53 
Mental Fatigue  
(MF) 
 
9.67 ± 4.54 7.23 ± 3.07 10.98 ± 4.00 13.77 ± 3.77 
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Table 4:  Association between Fatigue and Quality of Life 
 

























































†Correlation and p-value derived from comparisons between all domains of fatigue and all SF-36 subscales in the analysis.   
*Correlation and p-value in parentheses derived from comparisons between all domains of fatigue and SF-36 excluding “energy and 
vitality” subscale in the analysis. 
 
 
 
 
 
 
 
 
 
 
 
